Why the study?
Does dabigatran reduce the risk of osteoporotic fractures compared to warfarin in adults with nonvalvular atrial fibrillation?
Does dabigatran reduce the risk of osteoporotic fractures compared to warfarin in adults with nonvalvular atrial fibrillation?
Dabigatran is associated with a lower risk of osteoporotic fractures compared to warfarin in patients with nonvalvular atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Should not yet change anticoagulant choice in NVAF; leaves open need for RCTs to confirm fracture benefit.
Among adults with NVAF receiving anticoagulation, the use of dabigatran compared with warfarin was associated with a lower risk of osteoporotic fracture. Additional study, perhaps including randomized clinical trials, may be warranted to further understand the relationship between use of dabigatran vs warfarin and risk of fracture.
No takes yet. Share an insight, caveat, or question.
Lau et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: